Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hinge Health (HNGE) EBITDA (2024 - 2026)

Hinge Health's EBITDA history spans 2 years, with the latest figure at $27.3 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 30.35% to $27.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$538.6 million, a N/A change, with the full-year FY2025 number at -$528.3 million, down 4330.6% from a year prior.
  • EBITDA hit $27.3 million in Q4 2025 for Hinge Health, up from -$6.1 million in the prior quarter.
  • Over the last five years, EBITDA for HNGE hit a ceiling of $27.3 million in Q4 2025 and a floor of -$580.7 million in Q2 2025.